Text Size

Patient Acceptance of Whole Body Magnetic Resonance Angiography

This study has been completed.
Sponsor:
Collaborator:
Rigshospitalet, Denmark
Information provided by:
Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier:
NCT00556101
First received: November 8, 2007
Last updated: August 18, 2009
Last verified: August 2009
History of Changes
  Purpose

Investigation of how the patients experience whole body MRA. After the WB-MRA the patients will fill in a questionnaire, that contains questions about the WB-MRA procedure and how the patient felt during the examination.

We expect that the patients will report a high degree of satisfaction with the WB-MRA procedure, with little discomfort.


Condition Intervention
Atherosclerosis
Intermittent Claudication
MRI
 Procedure: Whole body magnetic resonance angiography

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Whole Body Magnetic Resonance Angiography: Questionnaire Examination of Patient Acceptance.

Resource links provided by NLM:

MedlinePlus related topics: Atherosclerosis
U.S. FDA Resources

Further study details as provided by Copenhagen University Hospital at Herlev:

Primary Outcome Measures:
  • Patient acceptance of Whole body MRA

Estimated Enrollment: 81
Study Start Date: November 2007
Study Completion Date: July 2009
Detailed Description:

WB-MRA is performed in patients referred for conventional x-ray based angiography. The WB-MRA is performed first in all patients.

After both examinations are completed the patients will be asked to fill in a questionnaire containing questions about their experience of the 2 procedures.

We will then compare the results for the procedures.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with pheripheral arterial disease

Criteria

Inclusion Criteria:

  • Symptomatic lower extremity ischemia (claudication, ischemic wounds)
  • Referred to digital subtraction angiography (DSA)

Exclusion Criteria:

  • Renal insufficiency (GFR < 30 ml/min)
  • Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker)
  • Dementia
  • Pregnancy/lactation
  • Allergy to gadolinium based MRI contrast agents
  • Acute disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00556101

Locations
Denmark
Department of Radiology, Herlev University Hospital
Herlev Copenhagen, Herlev, Denmark, DK2730
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Rigshospitalet, Denmark
Investigators
Study Chair: Henrik S Thomsen, Prof. MD. University Hospital at Herlev Copenhagen Denmark
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00556101     History of Changes
Other Study ID Numbers: WB-angio herlev 4
Study First Received: November 8, 2007
Last Updated: August 18, 2009
Health Authority: Denmark: National Board of Health

Keywords provided by Copenhagen University Hospital at Herlev:
Magnetic resonance
whole body
angiography
questionnaire

Additional relevant MeSH terms:
Atherosclerosis
Intermittent Claudication
Arteriosclerosis
Arterial Occlusive Diseases
 Vascular Diseases
Cardiovascular Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 22, 2013